Spots Global Cancer Trial Database for recurrent esophageal cancer

Every month we try and update this database with for recurrent esophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer	NCT00004236	Esophageal Canc... Gastric Cancer	pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel	NCT00006245	Esophageal Canc...	alvocidib paclitaxel	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer	NCT01231399	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri...	fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal...	19 Years -	City of Hope Medical Center
Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy	NCT01243398	Adenocarcinoma ... Esophageal Canc...	quality-of-life...	18 Years -	University of Oxford
Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus	NCT00002711	Esophageal Canc...	chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ...	18 Years -	Memorial Sloan Kettering Cancer Center
Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus	NCT00003487	Adenocarcinoma ...	Antineoplaston ...	18 Years - 99 Years	Burzynski Research Institute
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer	NCT00524186	Esophageal Canc... Gastric Cancer	fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological...	- 120 Years	Roswell Park Cancer Institute
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer	NCT01498289	Adenocarcinoma ... Esophageal Canc... Gastric Cancer	FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin	18 Years - 120 Years	SWOG Cancer Research Network
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery	NCT01705340	Adenocarcinoma ... HER2-positive B... Male Breast Can... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Stage IIIC Brea... Stage IIIC Esop... Stage IIIC Gast... Stage IV Breast... Stage IV Esopha... Stage IV Gastri...	Akt inhibitor M... trastuzumab lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer	NCT00003427	Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine...	irinotecan hydr... oxaliplatin	18 Years -	Memorial Sloan Kettering Cancer Center
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer	NCT00453323	Esophageal Canc...	Paclitaxel Capecitabine	18 Years -	National Cancer Center, Korea
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer	NCT00628368	Colorectal Canc... Esophageal Canc...	gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop...	18 Years -	National Cancer Institute (NCI)
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer	NCT00978549	Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain	docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera...	18 Years -	National Cancer Institute (NCI)
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer	NCT00025532	Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc...	iodine I 131 mo...	19 Years -	University of California, San Francisco
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
DX-8951f in Treating Patients With Metastatic Stomach Cancer	NCT00017212	Esophageal Canc... Gastric Cancer	exatecan mesyla...	18 Years -	Daiichi Sankyo
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy	NCT00017056	Esophageal Canc... Gastric Cancer	ixabepilone	18 Years -	Memorial Sloan Kettering Cancer Center
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach	NCT00004235	Esophageal Canc... Gastric Cancer	docetaxel irinotecan hydr...	18 Years -	Alliance for Clinical Trials in Oncology
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer	NCT00253708	Cancer	management of t... massage therapy pain therapy psychosocial as... quality-of-life...	18 Years - 120 Years	Beth Israel Deaconess Medical Center
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer	NCT00064259	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	oblimersen sodi... cisplatin fluorouracil	19 Years -	National Cancer Institute (NCI)
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer	NCT00010270	Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc...	LMB-9 immunotox...	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer	NCT00075738	Esophageal Canc...	cisplatin fluorouracil irinotecan hydr... leucovorin calc...	18 Years - 75 Years	National Cancer Institute (NCI)
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer	NCT00985192	Esophageal Canc... Gastric Cancer	everolimus laboratory biom...	18 Years -	Translational Oncology Research International
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus	NCT00003192	Esophageal Canc... Gastric Cancer	aminocamptothec...	18 Years -	University of Chicago
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer	NCT00093652	Esophageal Canc...	gefitinib oxaliplatin conventional su... neoadjuvant the... radiation thera...	18 Years - 120 Years	Roswell Park Cancer Institute
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer	NCT00064259	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage III Esoph... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	oblimersen sodi... cisplatin fluorouracil	19 Years -	National Cancer Institute (NCI)
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer	NCT00963092	Adenocarcinoma ... Esophageal Canc... Gastric Cancer	DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a...	16 Years -	National Cancer Institute (NCI)
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura	NCT00019825	Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc...	decitabine	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach	NCT00004127	Esophageal Canc... Gastric Cancer	FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin	18 Years -	University of Chicago
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction	NCT00107341	Esophageal Canc...	bortezomib carboplatin paclitaxel	18 Years -	Alliance for Clinical Trials in Oncology
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction	NCT00891878	Adenocarcinoma ... Esophageal Canc...	capecitabine sunitinib malat...	18 Years -	Alliance for Clinical Trials in Oncology
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus	NCT00016900	Esophageal Canc...	liposomal pacli...	18 Years -	Memorial Sloan Kettering Cancer Center
BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy	NCT00017043	Esophageal Canc... Gastric Cancer	ixabepilone	18 Years -	Bristol-Myers Squibb
Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer	NCT00281736	Esophageal Canc... Precancerous Co...	HPPH	18 Years -	Roswell Park Cancer Institute
Sorafenib. ICORG 06-41, V4	NCT01158287	Esophageal Canc... Gastric Cancer	sorafenib tosyl... laboratory biom...	18 Years -	Cancer Trials Ireland
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction	NCT00077545	Adenocarcinoma ... Recurrent Esoph... Stage IV Esopha...	triapine cisplatin	18 Years -	National Cancer Institute (NCI)
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer	NCT00040859	Esophageal Canc... Gastric Cancer	capecitabine oxaliplatin	18 Years -	Alliance for Clinical Trials in Oncology
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer	NCT00004236	Esophageal Canc... Gastric Cancer	pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer	NCT00397384	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Carcinoma of th... Gastrointestina... Metastatic Gast... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Pancr... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Pancre... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Unresectable Ex... Unresectable Ga...	cetuximab erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery	NCT01612546	Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Squamous Cell C... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... Stage IV Esopha... Stage IV Gastri...	cyclodextrin-ba... Laboratory biom... Pharmacological...	18 Years -	City of Hope Medical Center
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors	NCT00019435	Bladder Cancer Breast Cancer Colorectal Canc... Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc...	LMB-9 immunotox...	18 Years -	National Cancer Institute (NCI)
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer	NCT00978549	Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain	docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus	NCT00002711	Esophageal Canc...	chemotherapy cisplatin paclitaxel low-LET electro... low-LET photon ...	18 Years -	Memorial Sloan Kettering Cancer Center
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors	NCT01172028	Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer	Taxotere (Docet... Alimta (Pemetre...	18 Years -	University of Arizona
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus	NCT00005607	Esophageal Canc... Gastric Cancer	FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc...	18 Years -	National Cancer Institute (NCI)
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer	NCT01498289	Adenocarcinoma ... Esophageal Canc... Gastric Cancer	FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin	18 Years - 120 Years	SWOG Cancer Research Network
Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction	NCT00732745	Adenocarcinoma ... Esophageal Canc...	docetaxel oxaliplatin vandetanib placebo	18 Years -	Case Comprehensive Cancer Center
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer	NCT00075738	Esophageal Canc...	cisplatin fluorouracil irinotecan hydr... leucovorin calc...	18 Years - 75 Years	National Cancer Institute (NCI)
Irinotecan in Treating Patients With Esophageal or Stomach Cancer	NCT00003748	Esophageal Canc... Gastric Cancer	irinotecan hydr...	18 Years -	Jonsson Comprehensive Cancer Center
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus	NCT00003321	Esophageal Canc...	psychosocial as... quality-of-life...	-	European Organisation for Research and Treatment of Cancer - EORTC
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction	NCT00054457	Esophageal Canc... Gastric Cancer	capecitabine docetaxel	18 Years -	Alliance for Clinical Trials in Oncology
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer	NCT00963092	Adenocarcinoma ... Esophageal Canc... Gastric Cancer	DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a...	16 Years -	National Cancer Institute (NCI)
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection	NCT01249443	HIV Infection Recurrent Anal ... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Recurrent Metas... Recurrent Non-s... Recurrent Ovari... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Anal C... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu...	vorinostat diagnostic labo... pharmacological... carboplatin paclitaxel	18 Years -	AIDS Malignancy Consortium
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach	NCT00020761	Esophageal Canc... Gastric Cancer	irinotecan hydr... paclitaxel	18 Years -	Jonsson Comprehensive Cancer Center
FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer	NCT00098527	Adenocarcinoma ... Adenocarcinoma ... Recurrent Esoph... Recurrent Gastr...	romidepsin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer	NCT00354679	Esophageal Canc...	bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
European iNvestigation of SUrveillance After Resection for Esophageal Cancer	NCT03461341	Esophageal Canc... Metastatic Canc... Recurrent Esoph... Chemoradiation Chemotherapy Radiation Surgery	High intensity ...	18 Years -	St. James's Hospital, Ireland
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy	NCT01129206	Adenocarcinoma ... Adenocarcinomas... Recurrent Esoph... Squamous Cell C... Stage IV Esopha...	pralatrexate docetaxel fludeoxyglucose... positron emissi...	18 Years -	Ohio State University Comprehensive Cancer Center
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus	NCT00003326	Esophageal Canc...	paclitaxel	18 Years -	National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer	NCT00524186	Esophageal Canc... Gastric Cancer	fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological...	- 120 Years	Roswell Park Cancer Institute
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery	NCT01705340	Adenocarcinoma ... HER2-positive B... Male Breast Can... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Stage IIIC Brea... Stage IIIC Esop... Stage IIIC Gast... Stage IV Breast... Stage IV Esopha... Stage IV Gastri...	Akt inhibitor M... trastuzumab lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer	NCT00005599	Esophageal Canc... Gastric Cancer	bryostatin 1 paclitaxel	18 Years -	National Cancer Institute (NCI)
Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer	NCT00281736	Esophageal Canc... Precancerous Co...	HPPH	18 Years -	Roswell Park Cancer Institute
Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer	NCT00702884	Esophageal Canc...	sunitinib malat...	18 Years -	Ohio State University Comprehensive Cancer Center
S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	NCT00096031	Esophageal Canc...	cetuximab	18 Years - 120 Years	SWOG Cancer Research Network
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors	NCT01172028	Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer	Taxotere (Docet... Alimta (Pemetre...	18 Years -	University of Arizona
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	NCT00381706	Esophageal Canc...	cetuximab ECF IC FOLFOX	18 Years -	Alliance for Clinical Trials in Oncology
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura	NCT00019825	Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc...	decitabine	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: